Issue 9, 2018

A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity

Abstract

The interaction of Mn(II) with the non-steroidal anti-inflammatory drug mefenamic acid (Hmef) in the presence or absence of salicylaldoxime (H2sao) leads to the formation of the hexanuclear Mn(III) cluster [Mn6(O)2(mef)2(sao)6(CH3OH)4] 1, characterized as stepladder inverse-9-metallacrown-3 accommodating mefenamato ligands, or the mononuclear Mn(II) complex [Mn(mef)2(CH3OH)4], 2, respectively. Both complexes were characterized by physicochemical and spectroscopic techniques and the structure of complex 1 was characterized by X-ray crystallography. The overall magnetic behavior of compound 1 is antiferromagnetic with a high-spin well-isolated ground state S = 4. The in vitro cytotoxic effects of the complexes were evaluated against three cancer cell lines (HeLa, MCF-7 and A549 cells) as well as their combinatory activity with the well-known chemotherapeutic drugs cisplatin and 5-fluorouracil. Furthermore, in silico predictive tools have been employed to study the properties and acute rat toxicity and cell line cytotoxicity of the most active complex.

Graphical abstract: A step-ladder manganese(iii) metallacrown hosting mefenamic acid and a manganese(ii)–mefanamato complex: synthesis, characterization and cytotoxic activity

Supplementary files

Article information

Article type
Paper
Submitted
10 Mar 2018
Accepted
23 Mar 2018
First published
26 Mar 2018

New J. Chem., 2018,42, 6955-6967

A step-ladder manganese(III) metallacrown hosting mefenamic acid and a manganese(II)–mefanamato complex: synthesis, characterization and cytotoxic activity

A. Tarushi, G. D. Geromichalos, K. Lafazanis, C. P. Raptopoulou, V. Psycharis, N. Lalioti, A. A. Pantazaki, D. P. Kessissoglou, V. Tangoulis and G. Psomas, New J. Chem., 2018, 42, 6955 DOI: 10.1039/C8NJ01182F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements